Azilsartan

阿齐沙坦

Report date: 2026/01/06 15:22:04
NME

Base Information

Drug NameAzilsartan
Drug Alias Name阿奇沙坦azilsartanumazilsartanazilasartanAzilva +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Diabetes Mellitus +[5] 
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryJapan
Original Approved Date2012/01/18
Country/TerritoryUnited StatesMexicoArgentina +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co LtdHefei Amvite Pharmaceuticals Co LtdHefei Industrial Pharmaceutical Co Ltd +[5] 
Inactive CompaniesLee'S Pharmaceutical LtdHospital General De MexicoNanjing Huawe Medicine Technology Group Co Ltd +[5] 
Active IndicationsEssential HypertensionHypertension
Inactive IndicationsObesityDiabetes Mellitus, Type 2Diabetes Mellitus

Other Information

ATC CodeC09CA
Related LinksWikipediaDrugBankKEGG